UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031085
Receipt number R000035498
Scientific Title Randomized controlled trial evaluating single port thoracic surgery with x-Gate for spontaneous pneumothorax.
Date of disclosure of the study information 2018/03/20
Last modified on 2022/08/09 08:13:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized controlled trial evaluating single port thoracic surgery with x-Gate for spontaneous pneumothorax.

Acronym

Randomized controlled trial evaluating single port thoracic surgery with x-Gate for spontaneous pneumothorax.

Scientific Title

Randomized controlled trial evaluating single port thoracic surgery with x-Gate for spontaneous pneumothorax.

Scientific Title:Acronym

Randomized controlled trial evaluating single port thoracic surgery with x-Gate for spontaneous pneumothorax.

Region

Japan


Condition

Condition

spontaneous pneumothorax

Classification by specialty

Chest surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate safety and efficacy of single port
thoracic surgery with x-GATE for spontaneous pneumothorax in young patients.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

degree of postoperative pain (POD 7, Visual Analogue Scale(VAS))

Key secondary outcomes

pneumothorax recurrence, intraoperative blood loss, operation time, frequency of intraoperative and postoperative complications, duration of drainage, postoperative hospital stay


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

single-port thoracoscopic surgery with x-GATE

Interventions/Control_2

conventional three-port thoracoscopic surgery

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

35 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Patients who have spontaneous pneumothorax,
and the lesion (bulla or bleb) is located in the apex or peripheral side of lung.
(2) Patients who are over 15 years and under 35 of age at the time of consent.
(3) Patients who received informed consent to attend this study, and the agreements are provided in a document.

Key exclusion criteria

(1) Patients with secondary pneumothorax.
(2) Patients with severe liver or renal diseases.
(3) Patients with severe allergy.
(4) Patients who are judged ineligible by the investigator and the attending surgeon

Target sample size

24


Research contact person

Name of lead principal investigator

1st name Daisuke
Middle name
Last name Hokka

Organization

Kobe University International Clinical Cancer Research Center

Division name

Division of Thoracic Surgery

Zip code

650-0047

Address

1-5-1minatojimaminami-machi, Chuo-ku, Kobe, Japan

TEL

078-382-5750

Email

dhokka@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Hokka

Organization

Kobe University Graduate School of Medicine

Division name

Division of Thoracic Surgery

Zip code

650-0017

Address

7-5-2, Kusunoki-cho, Chuo-ku

TEL

0783825750

Homepage URL

http://www.med.kobe-u.ac.jp/gts/index.html

Email

dhokka@med.kobe-u.ac.jp


Sponsor or person

Institute

Kobe University Hospital

Institute

Department

Personal name



Funding Source

Organization

Kobe University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

KOBE Univ. Hosp. Clinical and Translation Research center

Address

7-5-2, Kusunoki-cho, Chuo-ku

Tel

0783826669

Email

chiken@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 03 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 02 Month 20 Day

Date of IRB

2018 Year 06 Month 18 Day

Anticipated trial start date

2018 Year 07 Month 24 Day

Last follow-up date

2022 Year 07 Month 24 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 01 Month 31 Day

Last modified on

2022 Year 08 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035498


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name